Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

205.96
-4.5700-2.17%
Pre-market: 203.80-2.1600-1.05%05:41 EDT
Volume:1.55M
Turnover:321.61M
Market Cap:10.45B
PE:32.63
High:211.73
Open:210.09
Low:205.84
Close:210.53
52wk High:217.12
52wk Low:147.95
Shares:50.75M
Float Shares:50.75M
Volume Ratio:1.07
T/O Rate:3.05%
Dividend:0.34
Dividend Rate:0.16%
EPS(TTM):6.31
EPS(LYR):35.34
ROE:24.54%
ROA:0.10%
PB:1.28
PE(LYR):5.83

Loading ...

Tiziana Life Sciences Completes Last Patient Visit in Phase 2a INFORM-MS Trial

TIPRANKS
·
Sep 21

Immunome initiated with a Buy at Alliance Global

TIPRANKS
·
Sep 21

Vertex Pharmaceuticals Incorporated : Leerink Partners Resumes Coverage with Outperform Rating; Target Price $594

THOMSON REUTERS
·
Sep 21

Ultragenyx price target raised to $35 from $32 at Barclays

TIPRANKS
·
Sep 21

Sino Biopharmaceutical Stock Rises 8.2% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 21

Innovative Drug Sector Heats Up: Spotlight on Pure-Play R&D Developers

Deep News
·
Sep 21

Correction to Vertex Material Listing Article on Sept. 17

Dow Jones
·
Sep 21

Prescient Therapeutics Requests Trading Halt Ahead of Capital Raising Announcement

TIPRANKS
·
Sep 21

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 19

Amneal Pharmaceuticals announces FDA approval and launch of Lanreotide

TIPRANKS
·
Sep 19

Sector Update: Healthcare

MT Newswires Live
·
Sep 19

Exchange-Traded Funds, US Equities Lower After Midday

MT Newswires Live
·
Sep 19

Electra Therapeutics indicated to open at $20, IPO priced at $15

TIPRANKS
·
Sep 18

Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday as Tech Rally Continues

MT Newswires Live
·
Sep 18

Sector Update: Healthcare

MT Newswires Live
·
Sep 18

Abeona Therapeutics ‘congratulated’ Ultragenyx on U.S FDA approval of UX111

TIPRANKS
·
Sep 18

Patent Expirations and R&D Gaps Create a Looming Biologic Shortfall, Potentially Costing the U.S. Healthcare System $189 Billion

Stock News
·
Sep 18

Tissue Repair Shareholders Approve Delisting and Equal Access Buyback

TIPRANKS
·
Sep 18

Vertex wins approval for 24/7 underground operations at Reward Gold Mine

TIPRANKS
·
Sep 18

Alterity Therapeutics to Spotlight MSA Program at ASX SMIDcaps Conference

TIPRANKS
·
Sep 18